Trials / Recruiting
RecruitingNCT06392854
Regional Lipolysis Insulin Regulation
Insulin Regulation of Regional Lipolysis
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Adults who gain most of their excess weight in the abdominal area typically do not respond to insulin in the same way as lean adults. Researchers are trying to understand why fat tissue responds differently in people with different body types.
Detailed description
Measure regional free fatty acid (FFA) release in volunteers with and without UBO under two different conditions that suppress lipolysis and a condition that markedly stimulates lipolysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin | 2 dose insulin infusion 4 hours |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2028-06-01
- Completion
- 2028-06-01
- First posted
- 2024-05-01
- Last updated
- 2026-04-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06392854. Inclusion in this directory is not an endorsement.